Scilex Holding (SCLX) Change in Cash (2020 - 2026)
Scilex Holding (SCLX) posted quarterly Change in Cash of -$1.6 million for Q1 2026, down 163.45% year-over-year from $2.5 million in Q1 2025, and down 139.34% quarter-over-quarter from $4.1 million in Q4 2025.
Scilex Holding (SCLX) Change in Cash (2020 - 2026) Analysis & Trends
Scilex Holding's Change in Cash history runs 7 years deep, the most recent figure standing at -$1.6 million for Q1 2026.
- In Q1 2026, Change in Cash fell 163.45% year-over-year to -$1.6 million; the TTM figure through Mar 2026 stood at -$2.4 million (down 180.93% YoY), while the FY2025 annual figure was $1.7 million, up 215.51% from the prior year.
- Change in Cash for Q1 2026 stood at -$1.6 million, down from $4.1 million in the prior quarter.
- The five-year high for Change in Cash was $30.1 million in Q2 2023, with the low at -$33.1 million in Q3 2023.
- The 5-year median for Change in Cash is -$1.5 million (2024), against an average of -$58058.8.
- Peak annual rise in Change in Cash reached 10177.14% in 2022, while the deepest fall reached 11874.91% in 2022.
- Scilex Holding's Change in Cash stood at -$299000.0 in 2022, then jumped by 1019.4% to $2.7 million in 2023, then sank by 276.21% to -$4.8 million in 2024, then soared by 184.17% to $4.1 million in 2025, then plunged by 139.34% to -$1.6 million in 2026.
- Business Quant data shows SCLX's Change in Cash at -$1.6 million in Q1 2026, $4.1 million in Q4 2025, and -$3.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | -1.27 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | -2.82 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 1.49 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 739.00 Mn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | - |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 1.95 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | -4.45 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | -727.00 Mn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Scilex Holding | 39.22 Mn | -73.57 Mn | 3.97 Mn | -2.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.60 Mn |
| Dec 31, 2025 | 4.08 Mn |
| Sep 30, 2025 | -3.22 Mn |
| Jun 30, 2025 | -1.70 Mn |
| Mar 31, 2025 | 2.53 Mn |
| Dec 31, 2024 | -4.84 Mn |
| Sep 30, 2024 | -1.55 Mn |
| Jun 30, 2024 | 6.89 Mn |
| Mar 31, 2024 | -1.96 Mn |
| Dec 31, 2023 | 2.75 Mn |
| Sep 30, 2023 | -33.15 Mn |
| Jun 30, 2023 | 30.06 Mn |
| Mar 31, 2023 | 2.89 Mn |
| Dec 31, 2022 | -299,000.00 |
| Sep 30, 2022 | -4.34 Mn |
| Jun 30, 2022 | -26.74 Mn |
| Mar 31, 2022 | 29.23 Mn |
| Dec 31, 2021 | -586,131.00 |
| Sep 30, 2021 | -426,387.00 |
| Jun 30, 2021 | 227,110.00 |